Abstract The purpose of this study was to determine whether women with endometrial cancer have a higher incidence of microscopic extrauterine spread in earlystage disease when diagnosed by hysteroscopy compared with being diagnosed by dilatation and curettage (D&C) or endometrial biopsy (Pipelle). We retrospectively reviewed the medical records of 110 patients who had undergone surgical staging for endometrial cancer from January 1997 to December 2003. They all had a preoperative histological diagnosis of endometrial carcinoma without evidence of extrauterine disease. Diagnosis was made by hysteroscopy in 64 patients (58.2%), by D&C in 17 (15.5%), and by endometrial biopsy using a Pipelle device in 29 (26.3%). The groups were compared for known prognostic factors for microscopic extrauterine spread, including age, grade, stage, and vascular space involvement, and did not differ in these parameters. Microscopic intraperitoneal disease and positive peritoneal cytology were considered the primary endpoints of this analysis. Peritoneal cytology was positive in three of 110 (2.7%) patients. The presence of positive peritoneal cytology was not associated with hysteroscopy as the diagnostic procedure. We conclude that diagnosis of endometrial cancer by hysteroscopy does not increase the risk of microscopic intraperitoneal spread compared with diagnosis by D&C or endometrial biopsy (Pipelle).
Introduction
Carcinoma of the endometrium is the most common gynecologic malignancy [1] . It is usually diagnosed as an organ-confined disease, with 5-year disease-free survival rates of 90% and 80% for patients with stages IA and B disease, respectively [2] . Among the clinicopathologic factors that can be evaluated pre-and intraoperatively, myometrial invasion and tumor grade are well-recognized prognostic factors and predictors of extrauterine spread [3, 4] . Although there is some debate on whether a positive peritoneal cytology worsens the prognosis in the absence of further extrauterine disease, patients with organ-confined endometrial carcinoma who present with malignant cells in the peritoneal washing must be classified as stage IIIA according to the current International Federation of Gynecology and Obstetrics (FIGO) staging classification [5] .
Diagnostic hysteroscopy is an effective method for evaluating the uterine cavity and visualizing pathologic conditions such as endometrial polyps, submucous fibroids, and focal endometrial abnormalities, including adenocarcinoma and its precursors [6, 7] . Albeit a common procedure, the role of hysteroscopy in diagnosing endometrial carcinoma is not established. The possibility of retrograde transtubaric seeding of malignant endometrial cells, an event related to increasing intrauterine pressure during hysteroscopy, is an issue of concern. Authors of a number of case reports believe, but have not proven, that there is abdominal dissemination of malignant cells during hysteroscopy in patients with endometrial carcinoma [8] [9] [10] [11] [12] .
The aim of the current study was to evaluate the incidence of positive peritoneal washings in patients with endometrial carcinoma and to evaluate the risk for positive peritoneal cytology depending on the mode of diagnosis.
Materials and methods
We conducted a retrospective chart review on all endometrial cancer patients who had surgical staging procedures in the Department of Gynecology, Tel-Aviv Sourasky Medical Center, Israel, between January 1997 and December 2003. Inclusion criteria were histologically proven endometrial carcinoma and informative peritoneal cytology. World Health Organization criteria were used for histologic classification. Surgical records and histology findings were used to determine the stage of disease according to the FIGO 1988 criteria [5] .
Hysteroscopy and dilatation and curettage (D&C) were carried out under general anesthesia. Pipelle biopsies were taken with no anesthesia. The D&C and Pipelle procedures were performed according to standard criteria. Hysteroscopy was done using a 5-mm hysteroscope (Richard Wolf, Knittlingen, Germany). The uterine cavity was distended by a continuous flow of 0.9% saline solution at a final flow of 150 ml/min. Each procedure took less than 3 min.
After being diagnosed as having endometrial cancer (2-4 weeks after the diagnostic procedure), all 110 patients underwent a standard surgical procedure of total abdominal hysterectomy and bilateral salpingo-oophorectomy; 56 of them (51%) also had pelvic lymph node sampling. Peritoneal cytology was obtained before the hysterectomy by peritoneal washing of the Douglas pouch with 100-200 ml of sterile saline solution. After centrifugation at 3,000 g for 10 min, the pellets were stained with May-Grunwald-Giemsa and Papanicolaou stains.
The choice of diagnostic procedure was determined by technical considerations (including HMO coverage) and physician's preference. Student's t-test/analysis of variance (ANOVA) and Fisher's exact tests were used for statistical analysis.
Results
This analysis is based on the data of all the patients (n=110) diagnosed in our department during the 7-year study period as having endometrial carcinoma with no evidence of extrauterine disease except for the results of peritoneal cytology. Seventeen patients (15.5%) were diagnosed by D&C, 29 (26.3%) by endometrial Pipelle biopsy, and 64 (58.2%) by hysteroscopy. The mean age of the patients was 66.5 years (range 30-90 years). Thirteen patients (12%) were stage IA, 64 (58%) were stage IB, 14 (13%) were stage IC, and 16 (15%) were stage II. Peritoneal cytology was positive in three of 110 cases (2.7%). Two of these patients had undergone hysteroscopy, and the third had a D&C procedure. The presence of malignant cells within the peritoneal fluid was not statistically associated with hysteroscopy (P=1.0).
Discussion
Endometrial assessment is done by biopsy, D&C, or hysteroscopy. Dilatation and curettage had for many years been the method of choice for diagnosing endometrial pathology. In 60% of D&C procedures, however, less than half of the uterine cavity is curetted, thereby raising questions about the accuracy of this method [13] . The Pipelle endometrial biopsy procedure is accurate, safe, economical, and acceptable to patients, clinicians, and pathologists. Its reported detection rates were 99.6% and 91% in postmenopausal and premenopausal women, respectively [14] . Diagnostic hysteroscopy combined with histological examination of an endometrial aspiration or biopsy is, though, considered the ''gold standard'' for diagnosing intrauterine abnormalities [15, 16] and is recommended in women with abnormal uterine bleeding by evidence-based guidelines.
Performance of hysteroscopy involves forcing a flow of saline through the uterus to distend the endometrial cavity and thereby facilitate visualization while increasing the pressure inside the uterine cavity. This has raised the possibility that hysteroscopy may cause peritoneal seeding of malignant cells from the endometrium into the peritoneal cavity, whereupon an organ-confined disease would be converted to a metastatic one, changing the prognosis and the course of treatment. The authors of several case reports suspected that distention and irrigation of the uterine cavity during fluid hysteroscopy might cause tumor cell dissemination into the abdominal cavity in patients with endometrial carcinoma [8] [9] [10] [11] [12] . Leveque et al. [17] reported a high incidence of positive peritoneal cytology (37%) in 19 patients with stage IA-C endometrial carcinoma and assumed that hysteroscopy, which had been carried out preoperatively in all 19 cases, might have been the reason for this. Conversely, Selvaggi et al. [18] did not find that fluid hysteroscopy increased the risk of microscopic intraperitoneal spread in 147 patients with endometrial cancer when comparing hysteroscopy to D&C as the diagnostic procedure. In their report on 113 patients with endometrial carcinoma, Obermair et al. [19] found that positive peritoneal cytology was associated with a history of hysteroscopy, but they did not show any significant differences in short-term disease-free survival that could be related to the diagnostic procedure [20] . Finally, Zerbe et al. [21] reported a statistical difference in the frequency of positive peritoneal cytology in 64 endometrial cancer patients who had hysteroscopy versus those who did not. Given these controversial findings, we searched our own endometrial cancer database for the incidence of positive peritoneal cytology and any links to the preoperative diagnostic procedure.
We found no correlation between the diagnostic procedure (hysteroscopy, Pipelle biopsy, or D&C) and microscopic extrauterine dissemination of malignant cells from the endometrium into the peritoneal cavity. We therefore conclude that hysteroscopy is a well-tolerated, accurate, and sensitive tool that allows direct visualization and biopsy of focal or diffuse abnormalities of the endometrium without exposing the patient to the risk of dissemination of malignant cells.
